Evidence map›Paper›PMID 33954839›Full record

Trial reportIntensive care medicine2021

Randomised controlled trial of oxygen therapy and high-flow nasal therapy in African children with pneumonia.

K Maitland, S Kiguli, P Olupot-Olupot, M Hamaluba, K Thomas, F Alaroker, R O Opoka, A Tagoola, V Bandika, A Mpoya and 12 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Intensive care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 6 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 6 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. High flow nasal cannula for respiratory support in term infants.The Cochrane database of systematic reviews · 2023
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 4 countries.

K Maitland *Department of Infectious Disease and and Institute of Global Health and Innovation, Division of Medicine, Imperial College, London, UK. k.maitland@imperial.ac.uk.ORCID http://orcid.org/0000-0002-0007-0645
S Kiguli *School of Medicine, Makerere University and Mulago Hospital Kampala, Kampala, Uganda.
P Olupot-Olupot *Faculty of Health Sciences, Mbale Campus and Mbale Regional Referral Hospital Mbale (POO, WO), Busitema University, Mbale, Uganda.
M Hamaluba *Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya.
K ThomasIntensive Care National Audit and Research Centre, London, UK.
F AlarokerSoroti Regional Referral Hospital, Soroti, Uganda.
R O OpokaSchool of Medicine, Makerere University and Mulago Hospital Kampala, Kampala, Uganda.
A TagoolaJinja Regional Referral Hospital Jinja, Jinja, Uganda.
V BandikaCoast General District Hospital, Mombasa, Kenya.
A MpoyaKilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya.
H MnjellaKilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya.
E NabawanukaSchool of Medicine, Makerere University and Mulago Hospital Kampala, Kampala, Uganda.
W OkirorFaculty of Health Sciences, Mbale Campus and Mbale Regional Referral Hospital Mbale (POO, WO), Busitema University, Mbale, Uganda.
M NakuyaSoroti Regional Referral Hospital, Soroti, Uganda.
D AromutSoroti Regional Referral Hospital, Soroti, Uganda.
C EngoruSoroti Regional Referral Hospital, Soroti, Uganda.
E OgudaKilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya.
T N WilliamsDepartment of Infectious Disease and and Institute of Global Health and Innovation, Division of Medicine, Imperial College, London, UK.
J F FraserCritical Care Research Group and Intensive Care Service, University of Queensland, The Prince Charles Hospital, Brisbane, Australia.
D A HarrisonIntensive Care National Audit and Research Centre, London, UK.
K RowanIntensive Care National Audit and Research Centre, London, UK.
COAST trial group
Soroti Hospital · UGKenya Medical Research Institute · KEMbale Hospital · UGMulago Hospital · UGIntensive Care National Audit & Research Centre · GBThe University of Queensland · AUImperial College London · GBJinja Hospital · UG

Funding

European & Developing Countries Clinical Trials Partnership (EDCTP) RIA2016S-1636Medical Research Council MR/L004364/1Wellcome Trust 202800/Z/16/Z
6 · The paper itself

Abstract

purposeThe life-saving role of oxygen therapy in African children with severe pneumonia is not yet established.

methodsThe open-label fractional-factorial COAST trial randomised eligible Ugandan and Kenyan children aged > 28 days with severe pneumonia and severe hypoxaemia stratum (SpO

resultsThe trial was stopped early after enrolling 1852/4200 children, including 388 in the severe hypoxaemia stratum (median 7 months; median SpO

conclusionsRespiratory support with HFNT showing potential benefit should prompt further trials.

Indexed as

Oxygen Inhalation TherapyPneumoniaChildHumansHypoxiaKenyaOxygenOxygenAfrican childrenClinical trialHigh-flow nasal therapyOxygenPneumonia

Identifiers

PMID33954839
PMCPMC8098782
OpenAlexW3159077844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.